Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • One Click Group flooded with customers desperate for FY24 tax refunds
    • News

    One Click Group flooded with customers desperate for FY24 tax refunds

    With Australians fighting the cost-of-living financial squeeze created by the Reserve Bank, One Click Group (ASX: 1CG) has seen a surge in customer demand for their Next Day Refund product within the first 2 days of FY24 ending, enticed by the swift turnaround on tax refunds.  The Next Day Refund product, which debuted last financial

    Read More
    Public
  • XJO to rise as US shares set fresh records
    • Market Update

    XJO to rise as US shares set fresh records

    The XJO is expected to edge higher on open this morning following a U.S which managed to finish in all-time highs. Their market is still arguably trading in a tight range and so our market is likely skeptical of their rise. Yesterday we held towards the day’s lows into the close. We continue to grind

    Read More
    Public
  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products

    Recreational cannabis use has been a global topic for debate in the past few years but cannabinoids, a naturally occurring compound in cannabis, are now gaining momentum as a treatment for managing pain, inflammation and various mental health conditions like depression and PTSD. For the past several months, Melodiol Global Health’s (ASX: ME1) subsidiary, Health

    Read More
    Public
  • SDI reports profit upgrade with cost cutting measure proving effective
    • News

    SDI reports profit upgrade with cost cutting measure proving effective

    Dental products manufacturer SDI Limited (ASX: SDI), has announced an uplift in expected profit for FY24, following a range of operational initiatives announced four months ago to reduce operating expenses.  SDI’s preliminary sales for FY24 (unaudited) revealed a 3.2% increase to $111.4 million, compared to $107.9 million in the previous year, marking a record twelve-month

    Read More
    Public
  • Mayne Pharma settles shareholder class action for $38M with no admission of guilt
    • News

    Mayne Pharma settles shareholder class action for $38M with no admission of guilt

    A standoff with shareholders dating back to 2014 has finally ended with Mayne Pharma (ASX: MYX) agreeing to settle a class action brought against them from shareholders, centering around allegations of misleading and deceptive conduct by the pharma company.  The origins of the class action trace back to investigations by the US Department of Justice

    Read More
    Public
  • XJO to open lower with Tech holding up US markets
    • Market Update

    XJO to open lower with Tech holding up US markets

    The XJO is expected to edge lower on open this morning following another lackluster night of sidewards movement from the U.S. Their futures have also edged into the red. Yesterday we kept in step with the past few sessions. Our market once again tried to move away from the middle of the range, but retraced

    Read More
    Public
  • «
  • ‹
  • 59
  • 60
  • 61
  • 62
  • 63
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.